Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Reduce Mental Health Stigma with Conversations

July 22, 2019

Talking about mental health is hard. Learn how health discussions in online communities can help reduce the mental health stigma.

HCPs Important Factor for Clinical Trial Participation

July 15, 2019

Healthcare professionals can be influential in a patient’s clinical trial participation, but the impact is more nuanced and multifaceted.

Long-Term Business Vision: Importance for Growth

June 29, 2019

Many digital health companies are driven financially by short-term gains. Read why that's less impactful than following a long-term business vision.

WHITEPAPER: Patient Interest and Participation in Clinical Trials

June 21, 2019

Health Union compiled data from more than 21,000 respondents to examine factors involved in patients’ interest and participation in clinical research.

Two phones are connected with a wire in the shape of a heart

Social Media Communities in Times of Physical Distance

August 20, 2020

While COVID-19 has resulted in a need to physically isolate, experts are concerned that the associated social isolation will have negative consequences.

Lung Cancer Patient-Reported Survey Data | 2020

August 13, 2020

Many people living with lung cancer report feeling a stigma associated with their condition, according to new Health Union survey data.

Patients play an active role in their treatment

Playing an Active Role in Treatment Yields More Confidence in Patients

August 4, 2020

Whether a person plays an active role in treatment or not, the majority of patients surveyed do not feel controlled on their current treatment plan.

Steroid Withdrawal Concerns in People with Atopic Dermatitis

July 30, 2020

More than half of people living with atopic dermatitis who have ever used topical corticosteroids say they are at least “somewhat concerned” about steroid withdrawal.

Healthcare Industry Thought Leadership

Contact